Abstract:BackgroundIn the China National Diabetes and Metabolic Disorders Study, age-standardised prevalence of total diabetes was 9·7%, accounting for 92·4 million adults, in China in 2010. Using clinical data and serum samples from this study, we aimed to investigate the prevalence of several organ-specific autoantibodies in patients with phenotypic type 2 diabetes.MethodsThis study included a nationally representative sample of 46 239 adults aged 20 years or older from 14 provinces and municipalities. After an overnight fast, participants had an oral glucose tolerance test. Previously diagnosed diabetes was self-reported. We randomly selected 4671 patients with diabetes and 1002 individuals with normal glucose tolerance as controls. Participants were screened centrally for glutamic acid decarboxylase autoantibodies (GAD-Ab), protein tyrosine phosphatase-like protein autoantibodies (IA2-Ab), and zinc transporter isoform 8 autoantibodies (ZnT8-Ab) using validated methods of the Islets Autoantibody Standardization Program 2012. We then assayed for thyroid peroxidase autoantibodies (TPO-Ab), tissue transglutaminase autoantibodies (tTG-Ab), and 21-hydroxylase autoantibodies (21-OH-Ab) in patients with islet autoantibody-positive diabetes (n=175), in randomly selected age-matched and sex-matched patients with islet autoantibody-negative diabetes (n=3052 for TPO-Ab, n=525 for tTG-Ab, and n=525 for 21-OH-Ab), and in individuals with normal glucose tolerance (n=954 for TPO-Ab, n=200 for tTG-Ab, and n=200 for 21-OH-Ab). We used multiple logistic regression analysis to determine the risk factor of each autoantibody. Ethics approval was granted by the Second Xiangya Hospital of Central South University, and all participants provided written informed consent.FindingsAfter adjustment for age and sex using results from the national population census, the standardised prevalence of autoimmune diabetes was 6·0% in all patients with diabetes, which corresponded to about 6 million adults in China. In patients with diabetes, the adjusted antibody positivity was 3·6% for GAD-Ab, 1·2% for IA2-Ab, and 1·5% for ZnT8-Ab. In those with autoimmune diabetes, the adjusted antibody positivity was 16·3% for TPO-Ab, 2·1% for tTG-Ab, and 1·8% for 21-OH-Ab. In patients with islet autoantibody-negative diabetes, the adjusted positivity was 10·2% for TPO-Ab, 0·3% for tTG-Ab, and 0·5% for 21-OH-Ab. In Chinese adults with autoimmune diabetes, those positive for GAD-Ab had a high risk for TPO-Ab positivity (odds ratio 2·39, 95% CI 1·35–4·24; p=0·0031) and tTG-Ab positivity (6·983, 1·24–39·22; p=0·027), and those positive for IA2-Ab had a high risk for tTG-Ab positivity (19·05, 3·14–115·61; p=0·0010). Patients positive for TPO-Ab were at high risk of being positive for 21-OHAb (7·48, 1·44–38·74; p=0·016) and vice versa (7·21, 1·35–38·45; p=0·021). Of note, women had a high risk for TPO-Ab positivity compared with men (3·83, 2·20–6·68; p<0·0001).InterpretationPatients positive for islet autoantibodies have a high risk for other organ-specific autoimmune diseases. Screening of TPO-Ab and tTG-Ab in Chinese individuals with autoimmune diabetes should be considered a priority.FundingNational Key Technology R&D Program (2012BAI02B04), the Grant of National Clinical Research Center for Metabolic Diseases (2013BAI09B12), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1195), and the Key Project of Chinese Ministry of Education (113050A).

215-LB: Comparison of Clinical and Serological Features among Type III APS, Isolated T1DM, and LADY/LADA

A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan

The Study on the Risk of Other Endocrine Glands Autoimmune Diseases in Patients with Type 1 Diabetes Mellitus

Association of Glutamic Acid Decarboxyase Antibody, Protein Tyrosine Phosphatase-2 Antibody, Zinc Transporter 8 Antibody and Autoimmune Thyroid Disease

Type 1 diabetes, celiac disease, and autoimmune thyroiditis autoantibodies in population-based type 2 diabetes patients

A Rare Case of Coexistence of Autoimmune Polyglandular Syndrome Type 3 with Growth Hormone Deficiency and Hyperthyroidism in a Patient with Pseudo-Turner's Syndrome.

Characterization of the clinical and genetic spectrum of autoimmune polyendocrine syndrome type 1 in Chinese case series

Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients

Characteristics of Patients with Type 1 Diabetes and Additional Autoimmune Disease in the DPV Registry

Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).

Latent Autoimmune Diabetes in Adults with Low-Titer GAD Antibodies: Similar Disease Progression with Type 2 Diabetes

Multiple Organ-Specific Autoantibodies in Patients with Phenotypic Type 2 Diabetes in China: a Post-Hoc Analysis of the China National Diabetes and Metabolic Disorders Study

Primary hyperaldosteronism associated with type 3 autoimmune polyendocrine syndrome: A rare case report

1982-LB: Prevalence of Autoimmune Antibodies Associated with LADA in Patients Treated with Type 2 Diabetes

[Detection of Thyroid Antibodies in Children with Type 1 Diabetes Mellitus].

Co-existence of type 1 diabetes and other autoimmune ailments in subjects with autoimmune thyroid disorders

Challenges in autoimmune polyendocrine syndrome type 2 with the full triad induced by anti-programmed cell death 1: a case report and review of the literature

Correlation between the islet autoantibodies and thyroid antibodies in patients with newly diagnosed nonketotic diabetes mellitus

Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity

Autoantibody "Subspecificity" In Type 1 Diabetes - Risk For Organ-Specific Autoimmunity Clusters In Distinct Groups

1463-P: Genetic Heterogeneity and Clinical Subtypes of Type 1 Diabetes